Homegrown Covid Vaccine: Globe Biotech gets nod for trial
Staff Correspondent
Staff Correspondent
Globe Biotech has got the licence to produce its homegrown coronavirus vaccine for human trial.
"We received the licence on December 28," Mohiuddin, manager of quality and regulation at Globe Biotech Ltd, told The Daily Star yesterday.
A research organisation may apply for permission to the Bangladesh Medical and Research Council (BMRC) to start the first phase of clinical trials next week.
On December 1, the Globe Biotech Ltd cancelled a contract with the icddr,b and assigned Dhaka-based Clinical Research Organization to hold the trials.
On October 5, Globe Biotech announced that its first vaccine candidate had passed in the pre-clinical trial on mice.